Prevalence and characteristics of tigecycline- and carbapenem-resistant adeN -truncated Acinetobacter baumannii : a genomic epidemiological analysis
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01843-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Ying Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affilia…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Tigecycline, Acinetobacter Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Zhejiang Province Medical and Health Technology Project.
Abstract (Originalsprache)
adeN -truncated Acinetobacter baumannii (ATAB) isolates are associated with elevated tigecycline resistance and enhanced virulence, yet its epidemic dynamics and genomic features remain poorly understood. This study aimed to investigate the epidemiology of ATAB isolates, identify infection risk factors, and assess their impact on patient prognosis. The prevalence of ATAB isolates in a tertiary care teaching hospital (Wenzhou, China) from January 2018 to December 2022 was determined via polymerase chain reaction (PCR) screening. Whole-genome sequencing and genomic analysis were conducted to explore the epidemiology and genomic characteristics of 254 ATAB isolates. Clinical data analysis was performed to identify risk factors for ATAB infection and its correlation with patient prognosis. The results of local sample analysis showed that adeN truncation was identified in 26.5% (486/1834) of the patient isolates, with the monthly prevalence peaking at 64.9% (24/37). The capsular types of ATAB isolates were primarily KL2, whereas adeN -complete isolates exhibited a greater capsular diversity. ATAB could evolve within the hospital and lead to multiple nosocomial clonal transmissions. Most ATAB isolates exhibited co-resistance to carbapenems and tigecycline. ICU admission and use of immunosuppressants were significant risk factors for ATAB isolate infection. Patients infected with ATAB isolates had significantly higher 28-day all-cause mortality (32.8%, 20/61) compared to those infected with adeN -complete isolates (11.5%, 7/61, P < 0.01). Bioinformatics analysis of the 18,946 completed and draft A. baumannii genome assemblies from the GenBank database showed that ATAB isolates were widely prevalent worldwide. This study highlights the importance of early identification and monitoring of ATAB isolates as a critical marker for hospital infection control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Ying Zhang, Tieli Zhou, Changrui Qian
Förderung
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province
- Zhejiang Province Medical and Health Technology Project
Zitieren
APA
Zhang, Y., Zhou, B., Kong, J., Hu, P., Liu, H., Zhao, D., Ye, J., Fu, Q., Zhou, T., & Qian, C. (2025). Prevalence and characteristics of tigecycline- and carbapenem-resistant adeN -truncated Acinetobacter baumannii : a genomic epidemiological analysis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01843-24
Vancouver
Zhang Y, Zhou B, Kong J, Hu P, Liu H, Zhao D, et al. Prevalence and characteristics of tigecycline- and carbapenem-resistant adeN -truncated Acinetobacter baumannii : a genomic epidemiological analysis. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01843-24
BibTeX
@article{Zhang2025,
author = {Zhang, Ying and Zhou, Beibei and Kong, Jingchun and Hu, Panjie and Liu, Haifeng and Zhao, Deyi and Ye, Jianzhong and Fu, Qingxia and Zhou, Tieli and Qian, Changrui},
title = {Prevalence and characteristics of tigecycline- and carbapenem-resistant adeN -truncated Acinetobacter baumannii : a genomic epidemiological analysis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01843-24}
}
EUVIMED